Paradoxical effect of smoking in the Spanish population with acute myocardial infarction or unstable angina: Results of the ARIAM register

Chest

Volumn 125, Issue 3, 2004, Pages 831-840

  Ruiz Bailén, Manuel ^a,f   De Hoyos, Eduardo Aguayo ^b   Reina Toral, Antonio ^b   Torres Ruiz, Juan Miguel ^c   Álvarez Bueno, Miguel ^d   Gómez Jiménez, Francisco Javier ^e  

^a HOSPITAL DE PONIENTE   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^c HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^d HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^e UNIVERSITY OF GRANADA   (Spain)

^f NONE   (Spain)

Author keywords

Acute myocardial infarction; Cigarette smoking; Mortality; Tobacco; Unstable angina

Indexed keywords

ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; NITRIC ACID DERIVATIVE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLEEDING; CARDIOGENIC SHOCK; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART ARRHYTHMIA; HEART MUSCLE CONDUCTION DISTURBANCE; HEART REINFARCTION; HEART RIGHT VENTRICLE FAILURE; HEART TAMPONADE; HUMAN; HYPERTENSION; IATROGENIC DISEASE; INFECTION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PERICARDITIS; PRIORITY JOURNAL; PROGNOSIS; REGISTER; RISK FACTOR; SMOKING HABIT; SPAIN; STATISTICAL SIGNIFICANCE; STROKE; UNSTABLE ANGINA PECTORIS;

EID: 1642342879     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.3.831     Document Type: Article

References (37)

1. Sauer WH, Berlin JA, Strom BL, et al. Cigarette yield and the risk of myocardial infarction in smokers. Arch Intern Med 2002; 11:162:300-306
2. LaCroix AZ, Lang J, Scherr P, et al. Smoking and mortality among older men and women in three communities. N Engl J Med 1991; 324:1619-1625
3. Wilhelmsen L. Coronary heart disease: epidemiology of smoking and intervention studies of smoking. Am Heart J 1988; 115:242-249
4. Fitzgerald GA, Oates JA, Nowak J. Cigarette smoking and hemostatic function. Am Heart J 1988; 115:267-271
5. Fuster V, Chesebro JH, Frye RL, et al. Platelet survival and the development of coronary artery disease in the young adult: effect of cigarette smoking, strong family history and medical therapy. Circulation 1981; 63:546-551
6. Ramsdale DR, Faragher EB, Bray CL, et al. Smoking and coronary artery disease assessed by routine coronary arteriography. Br Med J (Clin Res Ed) 1985; 290:197-200
7. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311:501-505
8. Tachmes L, Fernandez RJ, Sackner MA. Hemodynamic effects of smoking cigarettes of high and low nicotine content. Chest 1978; 74:243-245
9. Bellet S, DeGuzman NT, Kostis JB, et al. The effect of inhalation of cigarette smoke on ventricular fibrillation threshold in normal dogs and dogs with acute myocardial infarction. Am Heart J 1972; 83:67-76
10. Maouad J, Fernandez F, Barrillon A, et al. Diffuse or segmental narrowing (spasm) of the coronary arteries during smoking demonstrated on angiography. Am J Cardiol 1984; 53:354-355
11. Martin JL, Wilson JR, Ferraro N, et al. Acute coronary vasoconstrictive effects of cigarette smoking in coronary heart disease. Am J Cardiol 1984; 54:56-60
12. Nicod P, Winniford MD, Campbell WB, et al. Alterations in coronary blood flow induced by cigarette smoking: lack of relation to plasma arginine vasopressin concentrations. Am J Cardiol 1984; 54:667-668
13. Wald N, Howard S, Smith PG, et al. Association between atherosclerotic disease and carboxyhaemoglobin levels in tobacco smokers. BMJ 1973; 1:761-765
14. Ferreira R. The paradox of tobacco: smokers have a better post-infarct prognosis. Rev Port Cardiol 1998; 17:855-856
15. Sonke GS, Stewart AW, Beaglehole R, et al. Comparison of case fatality in smokers and non-smokers after acute cardiac event. BMJ 1997; 315:992-993
16. Grines CL, Topol EJ, O'Neill WW, et al. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation 1995; 91:298-303
17. Barbash GI, White HD, Modan M, et al. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation 1993; 87:53-58
18. Purcell IF, Newall N, Farrer M. Lower cardiac mortality in smokers following thrombolysis for acute myocardial infarction may be related to more effective fibrinolysis. QJM 1999; 92:327-333
19. Zahger D, Cercek B, Cannon CP, et al. How do smokers differ from nonsmokers in their response to thrombolsis? The TIMI-4 Trial. Am J Cardiol 1995; 75:232-236
20. Maynard C, Weaver WD, Litwin PE, et al. Hospital mortality in acute myocardial infarction in the era of reperfusion therapy (the Myocardial Infarction Triage and Intervention Project). Am J Cardiol 1993; 72:877-882
21. Klein HH, Hengstenberg C, Peuckert M, et al. Comparison of death rates from acute myocardial infarction in a single hospital in two different periods (1977-1978 versus 1988-1989). Am J Cardiol 1993; 71:518-523
22. Álvarez Bueno M, Vera Almazán A, Rodríguez García JJ, et al. Concept, development and objectives of project ARIAM. Med Intensiva 1999; 23:273-280
23. Aguayo de Hoyos E, Reina Toral A, Colmenero Ruiz M, et al. Analysis of delays in the treatment of acute coronary syndrome: data in the Registry ARIAM. Med Intensiva 1999; 23:280-287
24. Reina Toral A, Aguayo de Hoyos E, Colmenero Ruiz M, et al. Mortality in acute myocardial infarction. Med Intensiva 1999; 23:288-293
25. González Díaz F, Guerrero Gómez FJ, Martínez Coronel JF, et al. Fribrinolytic agents in the project ARIAM: exclusion reasons and complications. Med Intensiva 1999; 23:294-300
26. Saturno PJ, Felices F, Segura J, et al. Reducing time delay in the thrombolysis of myocardial infarction: an internal quality improvement project. ARIAM Project Group: analysis of the delay in acute myocardial infarction. Am J Med Qual 2000; 15:85-93
27. Azpitarte Almagro J, Cabadés O'Callaghan A, López Merino V, et al. Unstable angina: concept and classification. Rev Esp Cardiol 1995; 48:373-382
28. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-829
29. Killip T III, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients. Am J Cardiol 1967; 20:457-464
30. Ciruzzi M, Schargrodsky H, Rozlosnik J, et al. Frequency of family history of acute myocardial infarction in patients with acute myocardial infarction: Argentine FRICAS (Factores de Riesgo Coronario en América del Sur) Investigators. Am J Cardiol 1997; 80:122-127
31. Pasricha A, Batchelor W. When young hearts are broken: profiles of premature myocardial infarction. Am Heart J 2002; 143:4-6
32. Barbash GI, Reiner J, White HD, et al. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights; Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1995; 26:1222-1229
33. Herlitz J, Karlson BW, Karlsson T, et al. Predictors of death during 5 years after hospital discharge among patients with a suspected acute coronary syndrome with particular emphasis on whether an infarction was developed. Int J Cardiol 1998; 66:73-80
34. Molstad P. First myocardial infarction in smokers. Eur Heart J 1991; 12:753-759
35. Gourlay SG, Rundle AC, Barron HV. Smoking and mortality following acute myocardial infarction: results from the National Registry of Myocardial Infarction 2 (NRMI 2). Nicotine Tob Res 2002; 4:101-107
36. Hasdai D, Holmes DR Jr, Criger DA, et al. Cigarette smoking status and outcome among patients with acute coronary syndromes without persistent ST-segment elevation: effect of inhibition of platelet glycoprotein IIb/IIIa with eptifibatide: the PURSUIT trial investigators. Am Heart J 2000; 139:454-460
37. Marschner IC, Colquhoun D, Simes RJ, et al. Long-term risk stratification for survivors of acute coronary syndromes: results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study; LIPID Study Investigators. J Am Coll Cardiol 2001; 38:56-63